https://www.sitryx.com/news/sitryx-presents-new-preclinical-data-highlighting-pkm2-as-a-promising-metabolic-target-for-the-treatment-of-atopic-dermatitis-at-the-inflammatory-disease-skin-summit-2025
Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the...
presents newpreclinical datasitryxhighlightingpromising
https://cepi.net/sinergium-paves-way-latin-american-mrna-vaccines-new-preclinical-study
Sinergium paves the way for Latin American mRNA vaccines with new preclinical study
Backed by a US $1 million investment from CEPI, the exploratory project is among the first mRNA vaccine technologies to be assessed on the continent.
latin americanmrna vaccinesnew preclinicalpavesway
https://www.bioqubeventures.com/egle-therapeutics-to-present-new-preclinical-data-egl-003/
Egle Therapeutics to Present New Preclinical Data EGL-003, a Novel IL-2 Mutein for Selective...
Oct 6, 2025 - Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases
present newpreclinical dataegletherapeuticsnovel
https://www.sitryx.com/news/sitryx-presents-new-preclinical-data-highlighting-mthfd2-as-a-novel-metabolic-target-in-autoimmune-disease-at-acr-convergence-2025
Sitryx presents new preclinical data highlighting MTHFD2 as a novel metabolic target in autoimmune...
presents newpreclinical datasitryxhighlightingnovel